Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection.
Frigeni M, Besson C, Visco C, Fontaine H, Goldaniga M, Visentini M, Pulsoni A, Torres HA, Peveling-Oberhag J, Rossotti R, Zaja F, Rigacci L, Merli M, Dorival C, Alric C, Piazza F, Gentile M, Ferrari A, Pirisi M, Nassi L, Rattotti S, Frustaci A, Milella M, Cencini E, Defrancesco I, Ferretti VV, Bruno R, Hermine O, Arcaini L.
Frigeni M, et al. Among authors: bruno r.
Leukemia. 2020 May;34(5):1462-1466. doi: 10.1038/s41375-019-0687-2. Epub 2019 Dec 13.
Leukemia. 2020.
PMID: 31836855
No abstract available.